This clinical trial aims to improve treatment for high-risk patients by adding a targeted therapy to standard post-surgery immunotherapy The post Now Enrolling: The CLEAR research study is testing a new treatment combination for patients with operable non-small cell lung cancer appeared first on ECOG-ACRIN Advocacy Blog.
